Ondansetron HCL 4 MG tablet 500S
Ended Awarded Last action
- Contract number
- SPE2DR26F9PH9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,490
Award facts
- Contract value 100% obligated
- $19,489.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,489.56 to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 mg, an anti-nausea medication commonly used in military and federal healthcare settings. The contract is a firm fixed-price delivery order with an ultimate completion date of February 5, 2026, and was awarded on a non-set-aside, competitively awarded basis. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent company being Cencora, Inc., which operates under the AmerisourceBergen brand name.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The contract reflects the contractor's capability to efficiently fulfill government pharmaceutical procurement requirements for military treatment facilities, the Defense Health Agency, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9PH9?
SPE2DR26F9PH9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F9PH9 worth?
The government has obligated $19,490 on SPE2DR26F9PH9.
Is contract SPE2DR26F9PH9 an order under another contract?
Yes. SPE2DR26F9PH9 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9PH9 competed?
The extent of competition for SPE2DR26F9PH9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award